rs114554656

Variant summary

Our verdict is Benign. The variant received -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS1

The NM_001364171.2(ODAD1):​c.555C>T​(p.Ile185Ile) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000151 in 1,551,192 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.00060 ( 0 hom., cov: 31)
Exomes 𝑓: 0.00010 ( 0 hom. )

Consequence

ODAD1
NM_001364171.2 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -3.56

Publications

0 publications found
Variant links:
Genes affected
ODAD1 (HGNC:26560): (outer dynein arm docking complex subunit 1) This gene encodes a coiled-coil domain-containing protein that is a component of the outer dynein arm docking complex in cilia cells. Mutations in this gene may cause primary ciliary dyskinesia 20. [provided by RefSeq, May 2013]
ODAD1 Gene-Disease associations (from GenCC):
  • primary ciliary dyskinesia 20
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, ClinGen
  • primary ciliary dyskinesia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -17 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.73).
BP6
Variant 19-48311595-G-A is Benign according to our data. Variant chr19-48311595-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 413796.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-3.56 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.000605 (92/152162) while in subpopulation AFR AF = 0.002 (83/41528). AF 95% confidence interval is 0.00165. There are 0 homozygotes in GnomAd4. There are 47 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ODAD1NM_001364171.2 linkc.555C>T p.Ile185Ile synonymous_variant Exon 7 of 16 ENST00000674294.1 NP_001351100.1
ODAD1NM_144577.4 linkc.444C>T p.Ile148Ile synonymous_variant Exon 5 of 14 NP_653178.3 Q96M63-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ODAD1ENST00000674294.1 linkc.555C>T p.Ile185Ile synonymous_variant Exon 7 of 16 NM_001364171.2 ENSP00000501363.1 A0A6I8PTZ2

Frequencies

GnomAD3 genomes
AF:
0.000612
AC:
93
AN:
152044
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00200
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000393
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.000961
GnomAD2 exomes
AF:
0.000173
AC:
27
AN:
156408
AF XY:
0.0000844
show subpopulations
Gnomad AFR exome
AF:
0.00227
Gnomad AMR exome
AF:
0.000122
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000917
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000496
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000102
AC:
143
AN:
1399030
Hom.:
0
Cov.:
30
AF XY:
0.0000898
AC XY:
62
AN XY:
690056
show subpopulations
African (AFR)
AF:
0.00260
AC:
82
AN:
31598
American (AMR)
AF:
0.000112
AC:
4
AN:
35698
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25170
East Asian (EAS)
AF:
0.0000280
AC:
1
AN:
35726
South Asian (SAS)
AF:
0.0000126
AC:
1
AN:
79220
European-Finnish (FIN)
AF:
0.0000406
AC:
2
AN:
49254
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5696
European-Non Finnish (NFE)
AF:
0.0000426
AC:
46
AN:
1078686
Other (OTH)
AF:
0.000121
AC:
7
AN:
57982
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.458
Heterozygous variant carriers
0
8
16
24
32
40
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000605
AC:
92
AN:
152162
Hom.:
0
Cov.:
31
AF XY:
0.000632
AC XY:
47
AN XY:
74390
show subpopulations
African (AFR)
AF:
0.00200
AC:
83
AN:
41528
American (AMR)
AF:
0.000327
AC:
5
AN:
15268
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3464
East Asian (EAS)
AF:
0.000194
AC:
1
AN:
5156
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4818
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10604
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000147
AC:
1
AN:
68016
Other (OTH)
AF:
0.000951
AC:
2
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
4
8
13
17
21
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000344
Hom.:
0
Bravo
AF:
0.000729
Asia WGS
AF:
0.000289
AC:
1
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Primary ciliary dyskinesia Benign:2
Dec 31, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Aug 23, 2021
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

ODAD1-related disorder Benign:1
Apr 23, 2024
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.73
CADD
Benign
0.38
DANN
Benign
0.83
PhyloP100
-3.6
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs114554656; hg19: chr19-48814852; API